Secretory phospholipase A(2) inhibits epidermal growth factor-induced receptor activation.
Secretory phospholipase A(2) inhibits epidermal growth factor-induced receptor activation.
复制标题
DOI:
10.1006/excr.2002.5622
复制
发表时间:
2002-10
影响因子:
3.7
通讯作者:
Sheng Zhao;Xiao-Yan Du;Jun-Song Chen;Yuan‐cong Zhou;Jianguo Song
中科院分区:
文献类型:
--
作者:
Sheng Zhao;Xiao-Yan Du;Jun-Song Chen;Yuan‐cong Zhou;Jianguo Song
Secretory phospholipase A(2) (sPLA(2)) plays important roles in mediating various cellular processes, including cell proliferation, differentiation, apoptosis, and inflammatory response. In this study, we demonstrated that a basic sPLA(2) inhibits epidermal growth factor (EGF)-induced EGF receptor activation, as determined by autophosphorylation of EGF receptor, EGF-activated phospholipase D (PLD) activity, and phospholipase C-gamma(1) (PLC-gamma(1)) tyrosine phosphorylation in a human epidermoid carcinoma cell line, A-431. Treatment of cells with exogenous neutral sphingomyelinase (SMase) or a cell permeable ceramide analog, C(2)-ceramide, also caused similar inhibitory effects on EGF-induced activation of EGF receptor, tyrosine phosphorylation of PLC-gamma(1), and the activation of PLD. sPLA(2)-induced inhibition of EGF receptor was associated with arachidonic acid release, which was followed by an increase in intracellular ceramide formation. Both sPLA(2) and exogenous C(2)-ceramide are able to inhibit the proliferation of A-431. The data presented indicate for the first time that sPLA(2) downregulates the EGF receptor-mediated intracellular signal transduction that may be mediated by arachidonic acid and/or ceramide.